Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 76Polycystic Ovary Syndrome 3Neoplasms, Hormone-Dependent 3Neoplasm Metastasis 3Arthralgia 3Advanced Breast Cancer 3Osteoporosis 2Fractures, Bone 2Endometrial Neoplasms 2Carcinoma, Lobular 2Carcinoma, Intraductal, Noninfiltrating 2Carcinoma, Ductal, Breast 2Breast Diseases 2Breast Cancer Female 2Sexuality 1Sexual Dysfunctions, Psychological 1Neurotoxicity Syndromes 1Luminal B/HER2-negative Breast Cancer 1Leiomyoma 1Infertility 1Hot Flashes 1Hormone-receptor-positive Breast Cancer 1Hormone Receptor Positive Breast Carcinoma 1Hormone Receptor Positive Advanced Breast Cancer 1Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer 1HR+/HER2- Early Breast Cancer 1HR+/HER2+ Early Breast Cancer 1Fatigue 1Estrogen Receptor and/or Progesterone Receptor Positive 1Endometrial Stromal Tumors 1

Interventions

Zoledronic Acid 4Denosumab 4Toremifene 2Aromatase Inhibitors 2radium Ra 223 dichloride 1Vitamin D 1Tobacco Products 1Propofol 1Neuroleptanalgesia 1Midazolam 1Letrozole 1Hormone Replacement Therapy 1Heart Disease Risk Factors 1Exercise 1Etomidate 1Ethanol 1Cholecalciferol 1Cari-D-Tect 1Aspirin 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Fractures, Bone × Aromatase Inhibitors × Clear all
NCT00111241 2018-12-14

Changes in Knee Articular Cartilage Volume in Women on Aromatase Inhibitors

Monash University

Completed
115 enrolled 6 charts
Breast

Breast Neoplasms, Osteoporosis, Arthralgia, Fractures, Bone

NCT00766532 2012-09-14

Do Aromatase Inhibitors (AIs) Decrease Intestinal Calcium Absorption?

University of Wisconsin, Madison

Phase 4 Completed
12 enrolled 5 charts
Breast

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis, Fractures, Bone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡